Yasuyoshi Sato

639 total citations
47 papers, 380 citations indexed

About

Yasuyoshi Sato is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yasuyoshi Sato has authored 47 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Yasuyoshi Sato's work include Head and Neck Cancer Studies (11 papers), Colorectal and Anal Carcinomas (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Yasuyoshi Sato is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Colorectal and Anal Carcinomas (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Yasuyoshi Sato collaborates with scholars based in Japan and United States. Yasuyoshi Sato's co-authors include Shunji Takahashi, Shaw Watanabe, K. Lennert, Takashi Nakajima, M Motoi, Yukío Shimosato, Junichi Tomomatsu, Kenji Nakano, Akihiro Ohmoto and Makiko Ono and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Yasuyoshi Sato

43 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yasuyoshi Sato Japan	11	187	102	75	75	63	47	380
Prakash Neupane United States	12	324 1.7×	156 1.5×	100 1.3×	36 0.5×	91 1.4×	37	466
Kenneth Hennrick United States	5	66 0.4×	125 1.2×	78 1.0×	99 1.3×	94 1.5×	10	356
Chiung‐Ru Lai Taiwan	14	151 0.8×	47 0.5×	118 1.6×	42 0.6×	116 1.8×	24	504
Francesca Pagliuca Italy	12	132 0.7×	67 0.7×	64 0.9×	19 0.3×	112 1.8×	42	357
Roger Tell Sweden	10	166 0.9×	60 0.6×	73 1.0×	99 1.3×	49 0.8×	22	390
H. Jouhadi Morocco	12	215 1.1×	70 0.7×	111 1.5×	40 0.5×	94 1.5×	92	472
Nikolaus Möckelmann Germany	13	148 0.8×	86 0.8×	81 1.1×	31 0.4×	196 3.1×	32	396
Hanan Farghaly United States	12	160 0.9×	42 0.4×	78 1.0×	21 0.3×	126 2.0×	36	377
Mufaddal Moonim United Kingdom	10	94 0.5×	113 1.1×	38 0.5×	27 0.4×	87 1.4×	37	376
Taisuke Tsuji Japan	11	240 1.3×	227 2.2×	85 1.1×	31 0.4×	37 0.6×	41	488

Countries citing papers authored by Yasuyoshi Sato

Since Specialization

Citations

This map shows the geographic impact of Yasuyoshi Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuyoshi Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuyoshi Sato more than expected).

Fields of papers citing papers by Yasuyoshi Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuyoshi Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuyoshi Sato. The network helps show where Yasuyoshi Sato may publish in the future.

Co-authorship network of co-authors of Yasuyoshi Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuyoshi Sato. A scholar is included among the top collaborators of Yasuyoshi Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuyoshi Sato. Yasuyoshi Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuda, Naoki, Kazuhisa Toda, Ryosuke Oki, et al.. (2024). Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib. Endocrine Journal. 71(4). 363–371. 1 indexed citations

Ishigaki, Kazunaga, Naminatsu Takahara, Hiroki Oyama, et al.. (2024). Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database. Journal of Gastroenterology. 60(2). 247–256. 2 indexed citations

Sato, Yasuyoshi, Hiroharu Yamashita, Yukari Kobayashi, et al.. (2023). Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer. International Journal of Molecular Sciences. 24(23). 16602–16602. 3 indexed citations

Fukuda, Naoki, Ryosuke Oki, Xiaofei Wang, et al.. (2023). Comparison of Paclitaxel plus Carboplatin versus Observation in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck. Oncology. 101(8). 502–511. 1 indexed citations

Fujiwara, Yu, Yasuyoshi Sato, Naomi Hayashi, et al.. (2023). The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin. Journal of Geriatric Oncology. 14(5). 101523–101523. 5 indexed citations

Ohmoto, Akihiro, Kenji Nakano, Naoki Fukuda, et al.. (2023). Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study. PLoS ONE. 18(3). e0280508–e0280508. 1 indexed citations

Udagawa, Hibiki, Shunji Takahashi, Motohiro Hirao, et al.. (2022). Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer. Cancer Medicine. 12(2). 1269–1278. 9 indexed citations

Fukuda, Naoki, Kazuhisa Toda, Akihiro Ohmoto, et al.. (2022). A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients. Endocrine. 76(1). 70–77. 6 indexed citations

Sato, Yasuyoshi, Kenji Nakano, Xiaofei Wang, et al.. (2021). Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma. Cancers. 13(24). 6266–6266. 10 indexed citations

10.

Saito, Noriyuki, Yukari Kobayashi, Koji Nagaoka, et al.. (2021). Two distinct phenotypes of immunologically hot gastric cancer subtypes. Biochemistry and Biophysics Reports. 28. 101167–101167. 2 indexed citations

11.

Sato, Yasuyoshi, Naoki Fukuda, Yu Fujiwara, et al.. (2021). Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer. In Vivo. 35(2). 1211–1215. 14 indexed citations

12.

Fukuda, Naoki, Kazuhisa Toda, Akihiro Ohmoto, et al.. (2021). Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib. Anticancer Research. 41(3). 1683–1691. 7 indexed citations

13.

Hayashi, Naomi, Yasuyoshi Sato, Yu Fujiwara, et al.. (2021). Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy. Cancer Management and Research. Volume 13. 8377–8385. 12 indexed citations

14.

Nakano, Kenji, Keiko Hayakawa, Yuki Funauchi, et al.. (2020). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and Clinical Oncology. 14(1). 13–13. 6 indexed citations

15.

Fukuda, Naoki, Mayu Yunokawa, Yu Fujiwara, et al.. (2020). Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients. Cancer Reports. 4(2). e1322–e1322. 7 indexed citations

16.

Fukuda, Naoki, Kazuhisa Toda, Yu Fujiwara, et al.. (2020). Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib. In Vivo. 34(5). 2859–2864. 21 indexed citations

17.

Fukuda, Naoki, Yu Fujiwara, Xiaofei Wang, et al.. (2020). Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel. European Archives of Oto-Rhino-Laryngology. 278(8). 3037–3043. 5 indexed citations

18.

Sato, Yasuyoshi, Satoshi Matsusaka, Mitsukuni Suenaga, Eiji Shinozaki, & Nobuyuki Mizunuma. (2015). Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients. OncoTargets and Therapy. 8. 3329–3329. 16 indexed citations

19.

Sato, Yasuyoshi, Yuri Sato, Akiko Chino, et al.. (2014). A Case of a Child with an APC Pathogenic Mutation, Aberrant Expression of Splice Variants and Positive Family History of FAP. Japanese Journal of Clinical Oncology. 44(6). 602–606. 2 indexed citations

20.

Sato, Yasuyoshi, et al.. (1965). [CHEMOTHERAPEUTIC TREATMENT OF CANCER OF THE HEAD AND NECK].. PubMed. 11. 170–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact